Skip to main content

and
  1. No Access

    Article

    Effect of comorbidities on healthcare expenditures for patients on kidney replacement therapy considering the treatment modality and duration in a French cohort

    End-stage kidney disease (ESKD) is associated with a substantial economic burden. In France, the cost of care for such patients represents 2.5% of the total French healthcare expenditures but serves less than ...

    Isabella Vanorio-Vega, Panayotis Constantinou in The European Journal of Health Economics (2024)

  2. No Access

    Article

    New insights into epidemiological data and impact of the COVID-19 pandemic on IgA vasculitis in children and adults: a French nationwide cohort

    IgA vasculitis (IgAV) is a small size vasculitis for which epidemiologic data are strikingly lacking, especially about the adult form. Additionally, the COVID-19 pandemic seems to have profoundly modified the ...

    Valentin Maisons, Yanis Ramdani, Antoine Hankard in Rheumatology International (2023)

  3. Article

    Open Access

    Thrombotic microangiopathies after kidney transplantation in modern era: nosology based on chronology

    Thrombotic microangiopathies (TMAs) are rare but can be severe in kidney transplant.

    Florent Von Tokarski, Alexandre Fillon, Valentin Maisons in BMC Nephrology (2023)

  4. No Access

    Article

    Blood pressure management and long-term outcomes in kidney transplantation: a holistic view over a 35-year period

    Hypertension is a burden for most kidney transplant recipients. Whether respect of hypertension guidelines results in better outcomes is unknown.

    Lionel Tchatat Wangueu, Jean-Baptiste de Fréminville in Journal of Nephrology (2023)

  5. Article

    Open Access

    Study protocol for Vascular Access outcome measure for function: a vaLidation study In hemoDialysis (VALID)

    A functioning vascular access (VA) is crucial to providing adequate hemodialysis (HD) and considered a critically important outcome by patients and healthcare professionals. A validated, patient-important outc...

    Andrea K. Viecelli, Armando Teixeira-Pinto, Andrea Valks, Richard Baer in BMC Nephrology (2022)

  6. Article

    Open Access

    What is the impact of blood pressure on neurological symptoms and the risk of ESKD in primary and secondary thrombotic microangiopathies based on clinical presentation: a retrospective study

    The impact of blood pressure on neurological symptoms and risk of end-stage kidney disease (ESKD) is unknown in primary and secondary thrombotic microangiopathies (TMAs).

    Jean-Michel Halimi, Benjamin Thoreau, Florent von Tokarski in BMC Nephrology (2022)

  7. Article

    Open Access

    Standardised Outcomes in Nephrology – Chronic Kidney Disease (SONG-CKD): a protocol for establishing a core outcome set for adults with chronic kidney disease who do not require kidney replacement therapy

    Globally, over 1.2 million people die from chronic kidney disease (CKD) every year. Patients with CKD are up to 10 times more likely to die prematurely than progress to kidney failure requiring kidney replacem...

    Nicole Evangelidis, Benedicte Sautenet, Magdalena Madero, Allison Tong in Trials (2021)

  8. Article

    Open Access

    Early changes in renal resistive index and mortality in diabetic and nondiabetic kidney transplant recipients: a cohort study

    Renal resistive index (RI) predicts mortality in renal transplant recipients (RTR). However, its predictive value may be different according to the time of measurement. We analysed RI changes between 1 month a...

    Jean-Baptiste de Freminville, Louis-Marie Vernier, Jérome Roumy in BMC Nephrology (2021)

  9. Article

    Open Access

    Renal arteriography with endovascular ultrasound for the management of renal infarction patients

    Renal infarction (RI) is a rare disease with poor prognosis. Appropriate secondary prevention treatment is essential and requires an exhaustive etiological assessment. We aimed to determine whether invasive en...

    Fabrice Ivanes, Jean Dewaele, Caroline Touboul, Philippe Gatault in BMC Nephrology (2020)

  10. Article

    Open Access

    Contribution of medico-administrative data to the development of a comorbidity score to predict mortality in End-Stage Renal Disease patients

    Comorbidity scores to predict mortality are very useful to facilitate decision-making for personalized patient management. This study aim was to assess the contribution of medico-administrative data in additio...

    Adélaïde Pladys, Cécile Vigneau, Maxime Raffray, Bénédicte Sautenet in Scientific Reports (2020)

  11. No Access

    Article

    Arginine Vasopressin and Posterior Reversible Encephalopathy Syndrome Pathophysiology: the Missing Link?

    Posterior reversible encephalopathy syndrome (PRES) is a clinicoradiological entity characterized by a typical brain edema. Its pathogenesis is still debated through hypoperfusion and hyperperfusion theories, ...

    Bérenger Largeau, Olivier Le Tilly, Bénédicte Sautenet in Molecular Neurobiology (2019)

  12. No Access

    Article

    Forensic age estimation using computed tomography of the medial clavicular epiphysis: a systematic review

    Medicolegal physicians are increasingly called upon to aid in determining the administrative age group affiliation of refugees with questionable unaccompanied minor claims. According to guidelines for forensic...

    Coralie Hermetet, Pauline Saint-Martin in International Journal of Legal Medicine (2018)

  13. Article

    Open Access

    Standardised Outcomes in Nephrology—Polycystic Kidney Disease (SONG-PKD): study protocol for establishing a core outcome set in polycystic kidney disease

    Autosomal dominant polycystic kidney disease (ADPKD) is the most common potentially life threatening inherited kidney disease and is responsible for 5–10% of cases of end-stage kidney disease (ESKD). Cystic ki...

    Yeoungjee Cho, Benedicte Sautenet, Gopala Rangan, Jonathan C. Craig in Trials (2017)

  14. No Access

    Article

    Community pharmacist intervention in patients with renal impairment

    Background In France, community pharmacists do not have free access to patients’ lab results, and it is therefore impossible for them to identify patients with renal impairment. Objective

    Xavier Pourrat, Anne-Sophie Sipert in International Journal of Clinical Pharmacy (2015)

  15. No Access

    Article

    Deficits in information transfer between hospital-based and primary-care physicians, the case of kidney disease: a cross-sectional study

    Late recognition plays an important role in prognosis associated with kidney disease; thus, information transfer at hospital discharge regarding kidney disease is crucial. Whether it is notified in patients’ h...

    Bénédicte Sautenet, Agnès Caille, Bruno Giraudeau, Julie Léger in Journal of Nephrology (2015)